Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.

In conclusion, we successfully developed an integrated mRNA-lncRNA signature to refine the IPI model for predicting long-term survival of patients with DLBCL. PMID: 33221755 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33221755?dopt=Abstract

Source: Aging - November 18, 2020 Category: Biomedical Science Authors: Gao Q, Li Z, Meng L, Ma J, Xi Y, Wang T Tags: Aging (Albany NY) Source Type: research